Background Patients with coronavirus disease 2019 (COVID-19) who have underlying
malignancy have a higher mortality rate compared with those without cancer, although the …

Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …

Background Patients with lung cancers may have disproportionately severe coronavirus
disease 2019 (COVID-19) outcomes. Understanding the patient-specific and cancer-specific …

We established an international consortium to review and discuss relevant clinical evidence
in order to develop expert consensus statements related to cancer management during the …

A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has spread across the world, prompting the World Health Organization to declare the …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to dramatic changes
in oncology practice. It is currently unknown whether programmed death 1 (PD-1) blockade …

Objective: Patients with underlying diseases are more vulnerable to coronavirus disease
2019 (COVID-19). The purpose of this study was to investigate cancer incidence in patients …

PURPOSE To understand readiness measures taken by oncologists to protect patients and
health care workers from the novel coronavirus (COVID-19) and how their clinical decision …

Background Cancer patients constitute one of the highest-risk patient groups during the
COVID-19 pandemic. In this study, it was aimed to perform a systematic review and meta …

Background: Cancer patients represent a vulnerable population for COVID-19 illness. We
aimed to analyze outcomes of lung cancer patients affected by COVID-19 in a tertiary …